Xencor XNCR 深 滬
等待開盤 10-28 09:30:00 美东时间
29.99
+0.810
+2.78%
華盛通- 最 高30.25
- 今 開29.74
- 成交量 210.90万股
- 最 低 27.76
- 昨 收 29.18
- 總市值 22.30亿
- 52周最高 33.60
- 市盈率 靜 --
- 換手率 2.84%
- 52周最低 10.375
- 委 比 94.55%
- 總股本 7435.34万
- 歷史最高 58.345
- 量 比 0.77
- 振 幅 8.53%
- 歷史最低 5.75
- 每 手 1
- 風險率 5.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股前瞻 | 伊朗释放和平信号！期指转涨油价回落；SK海力士盘前升逾3%，将于盘后放榜！
伊朗释放和平信号！期指转涨油价回落近1%，美债收益率下滑；SK海力士盘前升逾3%，将于盘后公布业绩；康宁、可口可乐、波音业绩齐发！汇丰控股盘前跌近7%>>
10-27 20:27
美股牛股 | Surgery Partners涨47.6%，获57亿美元私有化收购；山脉资源升17.7%，与EQT达成合并协议；Lumentum涨8.2%，获StoneX首次给予买入评级
Surgery Partners涨47.6%，获57亿美元私有化收购；山脉资源升17.7%，与EQT达成合并协议；Lumentum涨8.2%，获StoneX首次给予买入评级
10-27 16:28
Xencor Drug Shows Unprecedented Profile in Colorectal Cancer: Analyst
At the ESMO Congress 2026, Xencor Inc. (NASDAQ:XNCR) shared updated results from the Phase 1 study of XmAb819 for advanced clear cell renal cell carcinoma (ccRCC). Robust Response Rates Across Expansion Cohorts The Phase 1 trial evaluated 119 participants across 11 intravenous dose cohorts. Within t...
10-27 01:00
Why Surgery Partners Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Shares of Surgery Partners Inc (NASDAQ:SGRY) rose sharply in pre-market trading after the Financial Times reported that Bon Secours Mercy Health is in late-stage talks to acquire a majority stake in Surgery Partners in a transaction valued at around $6 billion. Surgery Partners shares jumped 20.6% t...
10-26 17:13
美股大行评级 | 潜在涨幅227.21%！Jones Trading上调Rapport Therapeutics(RAPP)目标价至82美元，维持"买入"评级
今日重点评级关注：Jones Trading：维持Rapport Therapeutics"买入"评级，目标价从50美元升至82美元；摩根大通：维持SpaceX"超配"评级，目标价从240美元升至500美元
10-22 11:59
Wedbush Reiterates Outperform on Xencor, Maintains $30 Price Target
Wedbush analyst David Nierengarten reiterates Xencor (NASDAQ:XNCR) with a Outperform and maintains $30 price target.
10-21 21:00
美股大行评级 | 潜在涨幅919.61%！HC Wainwright上调NeuroSense Therapeutics目标价至52美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持NeuroSense Therapeutics"买入"评级，目标价从8美元升至52美元；HC Wainwright & Co.：维持艾切托"买入"评级，目标价从27美元升至34美元
09-29 08:33
Xencor shares are trading higher after Truist Securities reiterated the stock with a Buy rating and raised the price target from $27 to $29.
Xencor shares are trading higher after Truist Securities reiterated the stock with a Buy rating and raised the price target from $27 to $29.
09-29 03:38
美股大行评级 | 麦当劳目标价遭下调至320美元！现价仍有近3成上涨空间；戴尔、迈威尔、微软齐获机构看好
今日重点评级关注：HC Wainwright & Co.：维持Gossamer Bio"买入"评级，目标价从2美元升至90美元；巴克莱：维持Ultragenyx Pharmaceutical"超配"评级，目标价从32美元升至35美元
09-22 16:25
B of A Securities Maintains Neutral on Xencor, Raises Price Target to $26
B of A Securities analyst Alec Stranahan maintains Xencor (NASDAQ:XNCR) with a Neutral and raises the price target from $20 to $26.
09-22 01:42
